The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and half year ended on September 30, 2025 along with Limited Review ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Texofab's Board approved its unaudited standalone results for Q2 FY26 (ended Sept 30, 2025) and H1 FY26 on Nov 13, 2025. Revenue from Operations rose to Rs. 3,063.46 lakhs in Q2 (up ~15.8% YoY from Rs. 2,644.84 lakhs) and Rs. 5,871.14 lakhs in H1 (up ~12.5% YoY). Profit After Tax grew to Rs. 112.77 lakhs in Q2 and Rs. 214.38 lakhs in H1, a ~26% YoY jump for the half year, with H1 PBT margin expanding to ~4.8% from ~3.4% a year ago. EPS for H1 was Rs. 1.47 (basic) vs Rs. 1.69 prior, the dip reflecting a higher share count after a recent capital raise. Auditor Shah Kailash & Associates LLP issued an unqualified limited review report. On the balance sheet, total assets stood at Rs. 11,349.60 lakhs and total borrowings at ~Rs. 2,863 lakhs (debt/equity ~0.5x). However, cash flow from operations was sharply negative at -Rs. 364.89 lakhs in H1, driven mainly by a Rs. 773.60 lakh rise in trade receivables.
Strong topline and bottomline growth along with margin expansion is positive for shareholders, though the negative operating cash flow and ballooning trade receivables are yellow flags worth watching. The lower EPS is largely a function of equity dilution, not a deterioration in earnings quality.